Research Study

A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)
Principal Investigator 
Krishnan Ramanathan

Overview

Body Locations and Systems 
Peripheral Arterial Disease
ClinicalTrials.gov# 
NCT01732822
Status 
Closed to Recruitment
Study Start/End 
Mar 1, 2013 to Mar 1, 2018
Locations 
Diamond Health Care Centre
Name/Title 
Research Coordinator
Phone 
604-877-3728
Purpose of Study 

The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.